David Sandak
Broad Institute(US)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Chromatin Remodeling and Cancer, Glioma Diagnosis and Treatment, Cancer Cells and Metastasis, Ethics in Clinical Research
Most-Cited Works
- → Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomas(2020)185 cited
- → Barriers to accrual and enrollment in brain tumor trials(2019)77 cited
- → Renal medullary carcinomas depend upon SMARCB1 loss and are sensitive to proteasome inhibition(2019)50 cited
- → INNV-33. BARRIERS TO ACCRUAL AND ENROLLMENT IN BRAIN TUMOR TRIALS(2019)29 cited
- → Leveraging molecular datasets for biomarker-based clinical trial design in glioblastoma(2017)27 cited
- → Abstract 3453: Cancer Cell Line Factory: A systematic approach to create next-generation cancer model at scale(2020)2 cited
- → Renal medullary carcinomas depend upon SMARCB1 loss and are sensitive to proteasome inhibition(2018)
- → Author response: Renal medullary carcinomas depend upon SMARCB1 loss and are sensitive to proteasome inhibition(2019)
- → Abstract 1953: Accelerating prediction of pediatric and rare cancer vulnerabilities using next-generation cancer models(2017)
- → Abstract PR09: A systematic approach to create patient-derived models of rare tumors(2020)